Patents by Inventor Jack E. McKenzie

Jack E. McKenzie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7252637
    Abstract: A method of screening for possible onset of sepsis in a patient includes providing the patient with a transducer that automatically and periodically measures a first physiological parameter of the patient and transmits a first signal that is encoded with the measured parameter value, and receiving the first signal and automatically comparing the measured parameter value with at least one alarm limit. The first physiological parameter is body temperature, heart rate, respiration rate or a clinical indicator of sepsis. A conditional warning signal is asserted in the event that the measured parameter value bears a predetermined relationship to said alarm limit and an alarm signal is issued in the event that a physiological condition other than the condition that gave rise to the conditional warning signal is indicative of onset of sepsis.
    Type: Grant
    Filed: February 17, 2006
    Date of Patent: August 7, 2007
    Assignee: Mini-Mitter Co., Ltd.
    Inventors: Dennis M. Ebner, Jack E. McKenzie
  • Patent number: 7022070
    Abstract: A method of screening for possible onset of sepsis in a patient includes providing the patient with a transducer that automatically and periodically measures a first physiological parameter of the patient and transmits a first signal that is encoded with the measured parameter value, and receiving the first signal and automatically comparing the measured parameter value with at least one alarm limit. The first physiological parameter is body temperature, heart rate, respiration rate or a clinical indicator of sepsis. A conditional warning signal is asserted in the event that the measured parameter value bears a predetermined relationship to said alarm limit and an alarm signal is issued in the event that a physiological condition other than the condition that gave rise to the conditional warning signal is indicative of onset of sepsis.
    Type: Grant
    Filed: March 19, 2003
    Date of Patent: April 4, 2006
    Assignee: Mini-Mitter Co., Inc.
    Inventors: Dennis M. Ebner, Jack E. McKenzie
  • Publication number: 20030181815
    Abstract: A method of screening for possible onset of sepsis in a patient includes providing the patient with a transducer that automatically and periodically measures a first physiological parameter of the patient and transmits a first signal that is encoded with the measured parameter value, and receiving the first signal and automatically comparing the measured parameter value with at least one alarm limit. The first physiological parameter is body temperature, heart rate, respiration rate or a clinical indicator of sepsis. A conditional warning signal is asserted in the event that the measured parameter value bears a predetermined relationship to said alarm limit and an alarm signal is issued in the event that a physiological condition other than the condition that gave rise to the conditional warning signal is indicative of onset of sepsis.
    Type: Application
    Filed: March 19, 2003
    Publication date: September 25, 2003
    Inventors: Dennis M. Ebner, Jack E. McKenzie
  • Patent number: 6458762
    Abstract: Administration of low doses of hemoglobin minimizes damage to the myocardium after blockage and significantly reduces reperfusion injury. Hemoglobin exerts a pharmacological effect by increasing perfusion and blocking the molecular events leading to permanent injury following an ischemic episode. Additional benefits include a reduction in the number of post-ischemic arrhythmias, reduction in the incidence of restenosis, and improved contractile function in the area of risk.
    Type: Grant
    Filed: December 2, 1994
    Date of Patent: October 1, 2002
    Assignee: Baxter International, Inc.
    Inventors: Jack E. McKenzie, Kenneth E. Burhop
  • Patent number: 5877146
    Abstract: Administration of low doses of hemoglobin minimizes damage to the myocardium after blockage and significantly reduces reperfusion injury. Hemoglobin exerts a pharmacological effect by increasing perfusion and blocking the molecular events leading to permanent injury following an ischemic episode.
    Type: Grant
    Filed: August 7, 1995
    Date of Patent: March 2, 1999
    Assignee: Baxter International Inc.
    Inventors: Jack E. McKenzie, Kenneth E. Burhop